1. A single centre experience of prosthetic joint infection outcomes with outpatient parenteral antimicrobial therapy
- Author
-
Abdubadie Kutubi, Luke O'Brien, Ben Murphy, Patricia Fitzpatrick, Conor Hurson, Deepa Rajendran, Eoin Feeney, Patrick Mallon, and Sarmad Waqas
- Subjects
Outpatient parenteral antimicrobial therapy ,Prosthetic joint infections ,Arthroplasty ,Diabetes ,Readmission predictors ,Science (General) ,Q1-390 ,Social sciences (General) ,H1-99 - Abstract
Objectives: Prosthetic joint infection (PJI) is a serious complication following arthroplasties. This study assessed the clinical outcomes, readmission rates and financial impact of PJIs treated with outpatient parenteral antimicrobial therapy (OPAT). Methods: The study used prospectively collected data from the OPAT patient database at a tertiary care Irish hospital for PJI cases managed between 2015 and 2020. Data was analyzed using IBM-SPSS. Results: Forty-one patients with PJIs were managed via OPAT over five years, with median age of 71.6 years. Median duration of OPAT was 32 days. Hospital readmission occurred in 34% of cases. Reasons for readmission included progression of infection in 64.3%, unplanned reoperation in 21.4% and planned admission for joint revision in 14.3%. Type 2 Diabetes Mellitus (T2DM) was found to have a statistically significant association with unplanned readmission (OR 8.5, CI 95% 1.1–67.6; p
- Published
- 2023
- Full Text
- View/download PDF